Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLaura Guay, J. Brooks Jackson, Constance Ducar et al.|The Lancet|1999Cited by 1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|The Lancet|2003Cited by 525
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)Philippa Musoke, J. Brooks Jackson, Laura Guay et al.|AIDS|1999Cited by 217
Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized TrialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|Obstetrical & Gynecological Survey|2004Cited by 50